Literature DB >> 8869066

Dopamine D1, dopamine D2, and prolactin receptor messenger ribonucleic acid expression by the polymerase chain reaction in human meningiomas.

R S Carroll1, U M Schrell, J Zhang, K Dashner, P Nomikos, R Fahlbusch, P M Black.   

Abstract

Previous studies have suggested the presence of high-affinity dopamine D1 receptors and prolactin receptors in human cerebral meningiomas. In this study, using the polymerase chain reaction, we report the presence of the messenger ribonucleic acid (mRNA) for the dopamine D1 and D2 receptors and the prolactin receptor in meningioma tissue specimens and cell cultures derived from meningioma tissue. Dopamine D1 receptor mRNA was present in a majority of female tissue specimens and in all male tissue specimens. D2 receptor mRNA was detected in all specimens examined. Prolactin receptor mRNA was present in a little more than half of the female and male meningioma tumor specimens. The polymerase chain reaction products were directly sequenced to confirm the identity of these receptors in meningiomas and cell cultures. Ligand binding studies confirmed the presence of the dopamine D1 receptor in meningioma tissue specimens. In contrast, receptor studies with the dopamine D2 ligand [125I]4-iodospiperone failed to detect D2 binding in meningioma membrane preparations. These results suggest the existence of active dopamine D1 receptors in cerebral meningiomas.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8869066     DOI: 10.1097/00006123-199602000-00027

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  6 in total

Review 1.  Surgical indications for pituitary tumors during pregnancy: a literature review.

Authors:  Thomas Graillon; Thomas Cuny; Frédéric Castinetti; Blandine Courbière; Marie Cousin; Frédérique Albarel; Isabelle Morange; Nicolas Bruder; Thierry Brue; Henry Dufour
Journal:  Pituitary       Date:  2020-04       Impact factor: 4.107

Review 2.  Pathogenesis of peri-tumoral edema in intracranial meningiomas.

Authors:  Moncef Berhouma; Timothee Jacquesson; Emmanuel Jouanneau; François Cotton
Journal:  Neurosurg Rev       Date:  2017-08-24       Impact factor: 3.042

Review 3.  Molecular pathogenesis of meningiomas.

Authors:  Arie Perry; David H Gutmann; Guido Reifenberger
Journal:  J Neurooncol       Date:  2004-11       Impact factor: 4.130

Review 4.  Unique features of pregnancy-related meningiomas: lessons learned from 148 reported cases and theoretical implications of a prolactin modulated pathogenesis.

Authors:  Yosef Laviv; Victoria Ohla; Ekkehard M Kasper
Journal:  Neurosurg Rev       Date:  2016-06-16       Impact factor: 3.042

5.  Abundant immunohistochemical expression of dopamine D2 receptor and p53 protein in meningiomas: follow-up, relation to gender, age, tumor grade, and recurrence.

Authors:  G Trott; J F S Pereira-Lima; C G S Leães; N P Ferreira; L M Barbosa-Coutinho; M C Oliveira
Journal:  Braz J Med Biol Res       Date:  2015-03-03       Impact factor: 2.590

6.  Diagnosis, Treatment, and Management Strategy of Meningioma during Pregnancy.

Authors:  Ahmet Gurhan Gurcay; Ismail Bozkurt; Salim Senturk; Atilla Kazanci; Oktay Gurcan; Omer Faruk Turkoglu; Ethem Beskonakli
Journal:  Asian J Neurosurg       Date:  2018 Jan-Mar
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.